A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease
Clinical trial NCT02439970 · TERMINATED
Trial details
- NCT number
- NCT02439970
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-01-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.